Compared to controls, NAFLD patients had significantly higher percentages of CD3+ and CD4+ T cells and B cells, and a significantly lower percentage of Treg and CD4+ PD1+ T cells. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.